Evidence map›Paper›PMID 33563737›Full record

ArticleSaudi medical journal2021

Sociodemographic and clinical predictors of refractory type 2 diabetes patients: Findings from a case-control study.

Turki J Alharbi, Ayla M Tourkmani, Abdulaziz Bin Rsheed, Abood F Al Abood, Yasser K Alotaibi

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Turki J AlharbiFrom the Family and Community Medicine Department (Alharbi, Tourkmani, Bin Rsheed, Al Abood), Chronic Illness Center, Prince Sultan Military Medical City; and from the Department of Quality and Patient Safety (Alotaibi), Armed Forces Medical Services Directorate, Riyadh, Kingdom of Saudi Arabia.
Ayla M TourkmaniFrom the Family and Community Medicine Department (Alharbi, Tourkmani, Bin Rsheed, Al Abood), Chronic Illness Center, Prince Sultan Military Medical City; and from the Department of Quality and Patient Safety (Alotaibi), Armed Forces Medical Services Directorate, Riyadh, Kingdom of Saudi Arabia.
Abdulaziz Bin RsheedFrom the Family and Community Medicine Department (Alharbi, Tourkmani, Bin Rsheed, Al Abood), Chronic Illness Center, Prince Sultan Military Medical City; and from the Department of Quality and Patient Safety (Alotaibi), Armed Forces Medical Services Directorate, Riyadh, Kingdom of Saudi Arabia.
Abood F Al AboodFrom the Family and Community Medicine Department (Alharbi, Tourkmani, Bin Rsheed, Al Abood), Chronic Illness Center, Prince Sultan Military Medical City; and from the Department of Quality and Patient Safety (Alotaibi), Armed Forces Medical Services Directorate, Riyadh, Kingdom of Saudi Arabia.
Yasser K AlotaibiFrom the Family and Community Medicine Department (Alharbi, Tourkmani, Bin Rsheed, Al Abood), Chronic Illness Center, Prince Sultan Military Medical City; and from the Department of Quality and Patient Safety (Alotaibi), Armed Forces Medical Services Directorate, Riyadh, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify the sociodemographic and clinical predictors of uncontrolled diabetic patients, to identify high-risk and people with impaired glycemic control, to establish more effective strategies for reducing morbidity and mortality.

methodsThis case-control study of 8209 enrolled patients were included from the diabetes registry by Chronic Illness Center (CIC), Family and Community Medicin, Prince Sultan Military Medical City, Riyadh Saudi Arabia between February 2019 and February 2020. Cases are defined as patients with type II refractory diabetes having persistent HbA1c >9, not reach adequate glycemic control despite intensified therapy under specialist care (CIC) for at least 6 months. Controls were defined as patients with Hba1c ≤9. Multivariable regression analysis was used to identify predictors for patients with the persistent outcome of HbA1c >9%.

resultsOverall, a total of 1152 cases and 4555 controls were included. Patients with refractory diabetes were younger (mean: 58.5, standard deviation [SD]: 11.7) and females (63.4%). Duration of diabetes (13.3, SD: 7.4,

conclusionThe findings from this study helped classify the predictors of refractory patients with diabetes. Understanding refractory patients' predictors may help to develop new therapeutic strategies to boost their glycemic status safely.

Indexed as

Diabetes Mellitus, Type 2AdultAgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCase-Control StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedNutrition SurveysSaudi ArabiaYoung AdultAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsGlycated Hemoglobincase-controldiabetes registrypredictorsrefractory patientsSaudi Arabiatype II diabetes

Identifiers

PMID33563737
PMCPMC7989287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.